April 27, 2025 a 11:31 am

DHR: Dividend Analysis - Danaher Corporation

Danaher Corporation

Danaher Corporation showcases a steady yet modest dividend profile, making it a notable choice for investors seeking consistent income. With its near half-percent yield and a robust 33-year history of uninterrupted dividends, Danaher projects strong reliability without recent cuts. Coupled with a solid payout ratio, the company aligns with long-term dividend-focused strategies.

Overview

Detail Information
Sector Life Sciences
Dividend Yield 0.55%
Current Dividend Per Share 1.05 USD
Dividend History 33 years
Last Cut or Suspension None

Dividend History

Danaher's 33-year streak of unbroken dividend payments underscores its commitment to shareholders. Such a track record often represents a stable company with predictable cash flows, vital for income-focused investors.

Dividend Payment Chart
Year Dividend Per Share (USD)
2025 0.32
2024 1.08
2023 0.99
2022 0.89
2021 0.74

Dividend Growth

Observing Danaher's dividend growth over recent years highlights its capability to enhance shareholder returns. The incremental rises in both 3-year and 5-year growth rates reflect the company’s focus on rewarding its investors progressively.

Time Growth
3 years 13.19%
5 years 12.37%

The average dividend growth is 12.37% over 5 years. This shows moderate but steady dividend growth.

Dividend Growth Chart

Payout Ratio

A payout ratio provides insight into how much of a company’s earnings are distributed as dividends. Danaher reflects a conservative approach with an EPS-based payout ratio of 20% and an FCF ratio of 15%, indicating ample retained earnings for reinvestment.

Ratio Percentage
EPS-based 20%
Free cash flow-based 15%

Cashflow & Capital Efficiency

Analyzing a company's cash flow and capital usage reveals its operational efficiency and investment capability. Danaher demonstrates a balanced approach with strong yields and capital reinvestment ratios, underpinning capital-intensive growth strategies.

2024 2023 2022
Free Cash Flow Yield 3.16% 3.39% 4.32%
Earnings Yield 2.32% 2.80% 4.23%
CAPEX to Operating Cash Flow 21.54% 19.30% 13.52%
Stock-based Compensation to Revenue 1.21% 1.28% 0.94%
Free Cash Flow / Operating Cash Flow Ratio 79.19% 80.70% 86.48%

Balance Sheet & Leverage Analysis

The state of a company’s balance sheet indicates its financial flexibility and risk management ability. Danaher's prudent leverage and healthy ratios point to robust financial stewardship amidst operational demands.

2024 2023 2022
Debt-to-Equity 0.32 0.37 0.39
Debt-to-Assets 0.21 0.23 0.23
Debt-to-Capital 0.24 0.27 0.28
Net Debt to EBITDA 2.18 1.82 1.41
Current Ratio 1.43 1.68 1.89
Quick Ratio 1.05 1.37 1.52
Financial Leverage 1.57 1.58 1.68

Fundamental Strength & Profitability

Profitability metrics offer insights into operational efficiency and market competitiveness. Danaher showcases strong profitability margins paired with excellent ROE and ROA, indicating effective utilization of resources.

2024 2023 2022
Return on Equity 7.87% 8.91% 14.39%
Return on Assets 5.03% 5.64% 8.55%
Net Margin 16.33% 19.94% 22.91%
EBIT Margin 20.37% 22.31% 23.35%
EBITDA Margin 20.37% 31.39% 30.86%
Gross Margin 59.50% 58.74% 60.21%
Research & Development to Revenue 6.70% 6.29% 5.54%

Price Development

Price Development Chart

Dividend Scoring System

Criteria Description Score
Dividend Yield A modest yield contributing steady income.
Dividend Stability Reliability without disruptions.
Dividend Growth Steady increase over five years.
Payout Ratio Conservative and sustainable distribution.
Financial Stability Demonstrates strong balance sheet management.
Dividend Continuity Consistency with no recent interruptions.
Cashflow Coverage Solid cash reserves supporting payouts.
Balance Sheet Quality Robust financial health metrics.
Overall Score: 69/80

Rating

Danaher Corporation earns a solid dividend reliability and growth potential score, thereby reinforcing its image as a stable long-term investment. Its low yield reflects its focus on reinvestment and growth rather than high payouts, suiting patient investors with a preference for steady portfolio expansion.